Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
151
datasets available to search
ShareScore release 0.9.0
Dataset results
151 results for “Protein vaccines”
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer
ClinicalTrials.gov study NCT04117087. IPD Sharing: NO. Countries: 1. Publications: 0.
Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant
ClinicalTrials.gov study NCT01164514. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
ClinicalTrials.gov study NCT00529698. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)
ClinicalTrials.gov study NCT01441193. IPD Sharing: Not stated. Countries: 1. Publications: 13.
Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19)
ClinicalTrials.gov study NCT05007509. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1
ClinicalTrials.gov study NCT00106158. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers
ClinicalTrials.gov study NCT01513135. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults
ClinicalTrials.gov study NCT06684743. IPD Sharing: YES. Countries: 2. Publications: 3.
Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S
ClinicalTrials.gov study NCT01556945. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients
ClinicalTrials.gov study NCT05964361. IPD Sharing: NO. Countries: 1. Publications: 2.
Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
ClinicalTrials.gov study NCT00489931. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults
ClinicalTrials.gov study NCT01418235. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers
ClinicalTrials.gov study NCT04739917. IPD Sharing: Not stated. Countries: 1. Publications: 25.
Safety Study of a Recombinant Protein Vaccine to Treat Esophageal Cancer
ClinicalTrials.gov study NCT01003808. IPD Sharing: Not stated. Countries: 1. Publications: 7.
A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers
ClinicalTrials.gov study NCT00929396. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine
ClinicalTrials.gov study NCT01290419. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults
ClinicalTrials.gov study NCT01767402. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
ClinicalTrials.gov study NCT04990544. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines
ClinicalTrials.gov study NCT05323461. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents
ClinicalTrials.gov study NCT04954287. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.